COVID-19 Drug Development Recent Advances, New Perspectives and Applications
COVID-19 is a rampant worldwide problem. It is caused by the SARS-CoV-2 virus and is manifest in different variants. The Delta variant compromised existing therapeutic and preventive options for this disease and is beginning to be replaced by the Omicron variant. Through pharmaceutical biotechnology...
সংরক্ষণ করুন:
| অন্যান্য লেখক: | |
|---|---|
| বিন্যাস: | বৈদ্যুতিক গ্রন্থের অধ্যায় |
| ভাষা: | ইংরেজি |
| প্রকাশিত: |
IntechOpen
2022
|
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | DOAB: download the publication DOAB: description of the publication |
| ট্যাগগুলো: |
ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|
| সংক্ষিপ্ত: | COVID-19 is a rampant worldwide problem. It is caused by the SARS-CoV-2 virus and is manifest in different variants. The Delta variant compromised existing therapeutic and preventive options for this disease and is beginning to be replaced by the Omicron variant. Through pharmaceutical biotechnology, three different treatment approaches to COVID-19 have been developed: computer-aided drug design (CADD); rational drug design in the wet lab; and the advanced drug delivery system. These approaches are heavily influenced by advances in life sciences, such as the development of structural bioinformatics, the establishment of nanobiotechnology as a standard approach in drug design, and major advances in structural biology such as the development of the CryoEM method. This book will focus on providing possible solutions to the ongoing COVID-19 pandemic in light of these advances in life sciences. |
|---|---|
| দৈহিক বর্ননা: | 1 electronic resource (166 p.) |
| আইসবিএন: | intechopen.100969 9781803569901 9781803569895 9781803569918 |
| প্রবেশাধিকার: | Open Access |